Clinical Trial Results:
            (FONDACAST, del inglés FONDAparinux in patients with a plaster CAST)
Estudio Fase III, multicéntrico, aleatorizado, abierto, controlado, de dos grupos paralelos para evaluar la eficacia y seguridad de Fondaparinux frente a heparina de bajo peso molecular (Nadroparina) en pacientes que necesitan inmovilización rígida o semirígidasemirrígida al menos durante 21 días y hasta 45 días debido a una lesión aislada no quirúrgica por debajo de la rodilla.
    
| 
                 Summary 
         | 
        |
    EudraCT number  | 
        2008-004181-10 | 
    Trial protocol  | 
        ES DE FR NL IT | 
    Global completion date  | 
        
                                    04 Jul 2011
                             
         | 
    
| 
                 Paediatric regulatory details 
         | 
        |
    Is the trial part of an agreed EMA paediatric investigation plan?  | 
        
                                        No
                                 
         | 
    
    Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?  | 
        
                                        No
                                 
         | 
    
    Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?  | 
        
                                        No
                                 
         | 
    
| 
                 Results information 
         | 
        |
    Results version number  | 
        v1(current) | 
    This version publication date  | 
        
                                    12 Feb 2016
                             
         | 
    
    First version publication date  | 
        
                                    06 Nov 2014
                             
         | 
    
    Other versions  | 
        |
    Summary report(s)  | 
                                109350-FDAAA-Result-Summary | 
    
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.